Zanamivir-13C,15N2

Zanamivir-13C,15N2 is a stable isotope-labeled form of zanamivir, where specific carbon and nitrogen atoms are replaced by their isotopes, carbon-13 (13C) and nitrogen-15 (15N). This labeling enhances the molecule′s utility in various research applications, particularly in the detailed study of its interactions and dynamics within biological systems using advanced analytical techniques. Zanamivir is a neuraminidase inhibitor that plays a crucial role in the study of influenza virus replication. Neuraminidase, an enzyme on the surface of the influenza virus, facilitates the release of newly formed virus particles from infected cells by cleaving the sialic acid linkages that bind the emerging viral particles to the host cell surface. Zanamivir, including its isotope-labeled variant Zanamivir-13C,15N2, inhibits this enzyme, effectively blocking the release of the virus and hence its spread. The isotope labeling of Zanamivir-13C,15N2 makes it particularly valuable for research because it allows for more precise tracking and quantification of the compound in studies. Scientists use this labeled version to measure the absorption, distribution, metabolism, and excretion of zanamivir more accurately, as the distinct isotopic signatures help distinguish the compound from other molecules in complex biological matrices. Furthermore, Zanamivir-13C,15N2 is utilized in structural biology and biochemistry to study the binding and interaction of zanamivir with the neuraminidase enzyme. The incorporation of heavier isotopes facilitates the use of techniques like NMR spectroscopy to obtain high-resolution structural data and to observe how the inhibitor fits into the enzyme′s active site. This research helps in understanding how slight modifications to the inhibitor or the enzyme affect the binding efficiency and the overall mechanism of action.